Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Integrum

7.80 SEK

+5.83 %

Less than 1K followers

INTEG B

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+5.83 %
-14.00 %
-27.51 %
-27.91 %
-81.32 %
-49.52 %
-75.31 %
-86.83 %
-60.85 %

Integrum is active in medical technology. The company develops systems for skeletally anchored prostheses based on the developed OPRA implant system, which is later resold to hospitals worldwide. The implant is placed on the patient's leg with the help of titanium screws and is believed to improve the lives of a large number of patients with amputation. The company was founded in 1998 and has its headquarters in Mölndal.

Read more
Market cap
208.01M SEK
Turnover
1.05M SEK
Revenue
91.1M
EBIT %
-46.52 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
4/6
2026

Annual report '26

All
Press releases
ShowingAll content types
Regulatory press release3/5/2026, 6:45 AM

Integrum AB: Integrum publishes Interim Report for the third quarter 2025/26

Integrum
Regulatory press release3/5/2026, 6:45 AM

Integrum AB: Integrum publicerar delårsrapport för tredje kvartalet 2025/26

Integrum
Press release3/3/2026, 5:02 PM

Integrum AB: Integrum invites to presentation of Q3 2025/26 results

Integrum

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release3/3/2026, 5:02 PM

Integrum AB: Integrum bjuder in till presentation av Q3 2025/26

Integrum
Press release2/20/2026, 8:01 AM

DNB Carnegie Access: Integrum: Discontinuing coverage

Integrum
Regulatory press release2/11/2026, 2:40 PM

Integrum AB: Integrum optimerar organisationen för att ytterligare accelerera kommersialiseringen av OPRA Implant System

Integrum
Regulatory press release2/11/2026, 2:40 PM

Integrum AB: Integrum optimizes organization to further accelerate commercialization of OPRA Implant System

Integrum
Regulatory press release12/2/2025, 8:27 PM

Integrum AB: Integrums företrädesemission övertecknad

Integrum
Regulatory press release12/2/2025, 8:27 PM

Integrum AB: Integrum's rights issue oversubscribed

Integrum
Regulatory press release11/21/2025, 6:00 AM

Integrum AB: Integrum publishes Interim Report for Q2 2025/26

Integrum
Regulatory press release11/21/2025, 6:00 AM

Integrum AB: Integrum publicerar delårsrapport för Q2 2025/26

Integrum
Press release11/19/2025, 3:01 PM

Integrum AB: Invitation to the Second Quarter 2025/26 Results Presentation

Integrum
Press release11/19/2025, 3:01 PM

Integrum AB: Inbjudan till presentation av Integrums andra kvartal 2025/26

Integrum
Press release11/18/2025, 3:12 PM

Integrum AB: Teckningsperioden i Integrums företrädesemission har inletts

Integrum
Press release11/18/2025, 3:12 PM

Integrum AB: The subscription period in Integrum's rights issue has begun

Integrum
Regulatory press release11/14/2025, 7:00 AM

Integrum AB: Integrum publishes information document regarding rights issue

Integrum
Regulatory press release11/14/2025, 7:00 AM

Integrum AB: Integrum offentliggör informationsdokument avseende företrädesemission

Integrum
Regulatory press release11/13/2025, 4:56 PM

Integrum AB: Integrum offentliggör preliminära finansiella nyckeltal för andra kvartalet 2025/26

Integrum
Regulatory press release11/13/2025, 4:56 PM

Integrum AB: Integrum publishes preliminary financial key figures for the second quarter 2025/26

Integrum
Regulatory press release11/10/2025, 3:55 PM

Integrum AB: Integrum enters into bridge loan agreement to cover short-term working capital needs

Integrum
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.